Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development.

@article{Bellamy1999ClinicalTD,
  title={Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development.},
  author={Nicholas Bellamy},
  journal={Osteoarthritis and cartilage},
  year={1999},
  volume={7 4},
  pages={424-6}
}
Clinical trials guidelines should offer evidence-based recommendations, and, where evidence is lacking or absent, should reflect the considered opinion of experts in the field. Recent OsteoArthritis Research Society International (OARSI) guidelines encompass these principles and are the result of a Task Force Workshop involving representatives from academia, regulatory authorities and industry. Areas for continued development for trials of Structure Modifying Osteoarthritis Drugs (STMOAD… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…